BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20539321)

  • 1. Baculovirus-transduced bone marrow mesenchymal stem cells for systemic cancer therapy.
    Bak XY; Yang J; Wang S
    Cancer Gene Ther; 2010 Oct; 17(10):721-9. PubMed ID: 20539321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.
    Uchibori R; Okada T; Ito T; Urabe M; Mizukami H; Kume A; Ozawa K
    J Gene Med; 2009 May; 11(5):373-81. PubMed ID: 19274675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosafety assessment of human mesenchymal stem cells engineered by hybrid baculovirus vectors.
    Chen CY; Wu HH; Chen CP; Chern SR; Hwang SM; Huang SF; Lo WH; Chen GY; Hu YC
    Mol Pharm; 2011 Oct; 8(5):1505-14. PubMed ID: 21197956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgene expression and differentiation of baculovirus-transduced human mesenchymal stem cells.
    Ho YC; Chung YC; Hwang SM; Wang KC; Hu YC
    J Gene Med; 2005 Jul; 7(7):860-8. PubMed ID: 15712348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human embryonic stem cell-derived mesenchymal stem cells as cellular delivery vehicles for prodrug gene therapy of glioblastoma.
    Bak XY; Lam DH; Yang J; Ye K; Wei EL; Lim SK; Wang S
    Hum Gene Ther; 2011 Nov; 22(11):1365-77. PubMed ID: 21425958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
    Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
    Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant baculovirus containing the diphtheria toxin A gene for malignant glioma therapy.
    Wang CY; Li F; Yang Y; Guo HY; Wu CX; Wang S
    Cancer Res; 2006 Jun; 66(11):5798-806. PubMed ID: 16740719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced osteoinduction by mesenchymal stem cells transfected with a fiber-mutant adenoviral BMP2 gene.
    Tsuda H; Wada T; Yamashita T; Hamada H
    J Gene Med; 2005 Oct; 7(10):1322-34. PubMed ID: 15926193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combined use of viral transcriptional and post-transcriptional regulatory elements to improve baculovirus-mediated transient gene expression in human embryonic stem cells.
    Du J; Zeng J; Zhao Y; Boulaire J; Wang S
    J Biosci Bioeng; 2010 Jan; 109(1):1-8. PubMed ID: 20129073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baculoviral vector-mediated transient and stable transgene expression in human embryonic stem cells.
    Zeng J; Du J; Zhao Y; Palanisamy N; Wang S
    Stem Cells; 2007 Apr; 25(4):1055-61. PubMed ID: 17420229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression of a multidrug resistance gene (MDR1) and herpes simplex virus thymidine kinase gene in a bicistronic retroviral vector Ha-MDR-IRES-TK allows selective killing of MDR1-transduced human tumors transplanted in nude mice.
    Sugimoto Y; Sato S; Tsukahara S; Suzuki M; Okochi E; Gottesman MM; Pastan I; Tsuruo T
    Cancer Gene Ther; 1997; 4(1):51-8. PubMed ID: 9012451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid herpes simplex virus/Epstein-Barr virus amplicon viral vectors confer enhanced transgene expression in primary human tumors and human bone marrow-derived mesenchymal stem cells.
    Sia KC; Chong WK; Ho IA; Yulyana Y; Endaya B; Huynh H; Lam PY
    J Gene Med; 2010 Oct; 12(10):848-58. PubMed ID: 20963807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma.
    Zischek C; Niess H; Ischenko I; Conrad C; Huss R; Jauch KW; Nelson PJ; Bruns C
    Ann Surg; 2009 Nov; 250(5):747-53. PubMed ID: 19826249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baculovirus transduction of human mesenchymal stem cell-derived progenitor cells: variation of transgene expression with cellular differentiation states.
    Ho YC; Lee HP; Hwang SM; Lo WH; Chen HC; Chung CK; Hu YC
    Gene Ther; 2006 Oct; 13(20):1471-9. PubMed ID: 16763663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice.
    Gao Y; Yao A; Zhang W; Lu S; Yu Y; Deng L; Yin A; Xia Y; Sun B; Wang X
    Oncogene; 2010 May; 29(19):2784-94. PubMed ID: 20190814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.